Silencing FGFR4 reduces cellular adhesion in CRC [86], while knocking out FGFR4 in CRC by CRISPR-Cas9 upregulates E-cadherin and downregulates EMT mediators to reduce the tumor metastasis ability [65,86]. The gene discussed is CDH1; the disease is colorectal carcinoma.